
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
Khadija Khan, Gila Lustig, Kajal Reedoy, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 10
Khadija Khan, Gila Lustig, Kajal Reedoy, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 10
Showing 10 citing articles:
Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike
Qian Wang, Yicheng Guo, Liyuan Liu, et al.
Nature (2023) Vol. 624, Iss. 7992, pp. 639-644
Open Access | Times Cited: 150
Qian Wang, Yicheng Guo, Liyuan Liu, et al.
Nature (2023) Vol. 624, Iss. 7992, pp. 639-644
Open Access | Times Cited: 150
EG.5 (Eris) and BA.2.86 (Pirola) two new subvariants of SARS-CoV-2: a new face of old COVID-19
Abdolreza Esmaeilzadeh, Fereshteh Ebrahimi, Armin Jahani Maleki, et al.
Infection (2024) Vol. 52, Iss. 2, pp. 337-343
Closed Access | Times Cited: 7
Abdolreza Esmaeilzadeh, Fereshteh Ebrahimi, Armin Jahani Maleki, et al.
Infection (2024) Vol. 52, Iss. 2, pp. 337-343
Closed Access | Times Cited: 7
SARS-CoV-2 BA.2.86 (“Pirola”): Is it Pi or Just Another Omicron Sublineage?
Daniele Focosi, Pietro Giorgio Spezia, Fabrizio Maggi
Vaccines (2023) Vol. 11, Iss. 11, pp. 1634-1634
Open Access | Times Cited: 13
Daniele Focosi, Pietro Giorgio Spezia, Fabrizio Maggi
Vaccines (2023) Vol. 11, Iss. 11, pp. 1634-1634
Open Access | Times Cited: 13
Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike
Qian Wang, Yicheng Guo, Liyuan Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Qian Wang, Yicheng Guo, Liyuan Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Evaluation of the cross reactivity of neutralising antibody response in vaccinated human and convalescent hamster sera against SARS-CoV-2 variants up to and including JN.1 using an authentic virus neutralisation assay
Naomi S. Coombes, Kevin R. Bewley, Yann Le Duff, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Naomi S. Coombes, Kevin R. Bewley, Yann Le Duff, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
The SARS-CoV-2 Omicron sub-variant BA.2.86 is attenuated in hamsters
Vanessa Herder, Diogo Corrêa Mendonça, Nicole Upfold, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Vanessa Herder, Diogo Corrêa Mendonça, Nicole Upfold, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Neutralisation of SARS-CoV-2 Omicron subvariants BA.2.86 and EG.5.1 by antibodies induced by earlier infection or vaccination
Ria Lassaunière, Charlotta Polacek, Sharmin Baig, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Ria Lassaunière, Charlotta Polacek, Sharmin Baig, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
A triggering structure of SARS-CoV-2 BA.2.86 spike upon ACE2 binding for receptor-binding domain up
Takao Hashiguchi, Hisano Yajima, Yuki Anraku, et al.
Research Square (Research Square) (2024)
Open Access
Takao Hashiguchi, Hisano Yajima, Yuki Anraku, et al.
Research Square (Research Square) (2024)
Open Access
Broad-spectrum coronavirus neutralization induced by hetero RBD-Fc protein vaccine
Chaoyue Zhao, Guonan Cai, Shuai Jiang, et al.
Authorea (Authorea) (2024)
Open Access
Chaoyue Zhao, Guonan Cai, Shuai Jiang, et al.
Authorea (Authorea) (2024)
Open Access
Post-pandemic memory T-cell response to SARS-CoV-2 is durable, broadly targeted and cross-reactive to hypermutated BA.2.86
Rofhiwa Nesamari, Millicent A. Omondi, Maxine A. Höft, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Rofhiwa Nesamari, Millicent A. Omondi, Maxine A. Höft, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access